Skip to content

Efficacy and safety of gastrointestinal endoscopic surgical instrument control system (FASTER system)-assisted endoscopic full-thickness dissection for gastric submucosal tumors: a prospective, single-blind, single-center, pilot randomized controlled trial

Efficacy and safety of gastrointestinal endoscopic surgical instrument control system (FASTER system)-assisted endoscopic full-thickness dissection for gastric submucosal tumors: a prospective, single-blind, single-center, pilot randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122001
Enrollment
Unknown
Registered
2026-04-08
Start date
2026-04-10
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric submucosal tumors

Interventions

Trial group:Implement FASTER system-assisted EFTR
Control group:Implement standard EFTR

Sponsors

Zhongshan Hospital affiliated to Fudan University; Shanghai Xuhui Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age >= 18 and <= 80 years; (2) Normal body temperature prior to surgery; (3) Preoperative assessments (including gastroscopy, endoscopic ultrasound, CT, and MRI) confirm suitability for EFTR; (4) Preoperative evaluation indicates a submucosal tumor originating from the gastric muscularis propria, with a maximum diameter <5 cm; (5) Absence of other organic diseases of the stomach and colorectum; (6) Single lesion to be resected in one EFTR procedure; (7) The patient and family members are capable of understanding the study protocol, willing to participate in the study, and able to provide written informed consent.

Exclusion criteria

Exclusion criteria: (1) Age 80 years; (2) Immunocompromised individuals, or those who undergoing treatment with immunosuppressive agents; (3) Patients with concurrent organic diseases of the stomach and colorectum; (4) Patients with a history of gastric surgery that may affect postoperative outcomes; (5) Pregnant or lactating women; (6) Patients with conditions such as severe emphysema, interstitial pneumonia, or ischemic heart disease who cannot tolerate anesthesia and surgery; (7) Patients with contraindications to EFTR; (8) Patients or family members are unable to understand the conditions and objectives of this study.

Design outcomes

Primary

MeasureTime frame
Procedure time;

Secondary

MeasureTime frame
R0 resection rate;Resection time;Closure time;Incidence of postoperative delayed perforation;Incidence of postoperative delayed bleeding;Incidence of postoperative infection;Incidence of postoperative electrocoagulation syndrome;Incidence of postoperative gas-related complications;

Countries

China

Contacts

Public ContactZhong Yunshi

Zhongshan Hospital affiliated to Fudan University; Shanghai Xuhui Central Hospital

zhong.yunshi@zs-hospital.sh.cn+86 135 6462 3481

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026